BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Amneal Pharmaceuticals, Inc. (AMRX) on Friday reported a loss of $98.6 million in its fourth quarter.

On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of 40 cents. Earnings, adjusted for asset impairment costs and amortization costs, came to 14 cents per share.

The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 7 cents per share.

The pharmaceutical company posted revenue of $617 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $630.7 million.

For the year, the company reported that its loss narrowed to $84 million, or 48 cents per share. Revenue was reported as $2.39 billion.

Amneal expects full-year earnings in the range of 53 cents to 63 cents per share, with revenue in the range of $2.55 billion to $2.65 billion.

Amneal shares have declined 9% since the beginning of the year. The stock has more than doubled in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMRX at https://www.zacks.com/ap/AMRX